openPR Logo
Press release

Leigh Syndrome Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight | PTC Therapeutics, Abliva AB

03-24-2025 08:46 AM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Leigh Syndrome Market

Leigh Syndrome Market

DelveInsight's comprehensive report titled "Leigh Syndrome Market Insights, Epidemiology, and Market Forecast - 2034" offers a detailed analysis of Leigh syndrome. The report presents historical and projected epidemiological data covering Total Prevalent Cases and Diagnosed Prevalent Cases of Leigh syndrome further segmented by Onset, Mutation, and Gender. In addition to epidemiology, the market report encompasses various aspects related to the patient population. These aspects include the diagnosis process, prescription patterns, physician perspectives, market accessibility, treatment options, and prospective developments in the market across seven major markets: the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan, spanning from 2020 to 2034.

Discover which therapies are expected to grab the Leigh Syndrome Market Share @ Leigh Syndrome Market Outlook- https://www.delveinsight.com/sample-request/leigh-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Leigh Syndrome Market Report
• In March 2025, PTC Therapeutics announced a study is to assess the safety of vatiquinone in participants with inherited mitochondrial disease who had prior exposure to vatiquinone in a PTC/BioElectron sponsored (previously Edison) clinical study or treatment plan.
• During the analysis of Leigh syndrome, it was determined that the prevalence of the condition is approximately 1 in 30,000 to 1 in 40,000 individuals at birth.
• During the analysis, it was noted that 64% of Leigh syndrome patients exhibited a mutation in nuclear DNA. Among nuclear DNA genes, SURF1 was found to be the most prevalent, present in 72% of cases, among a total of 18 different nuclear DNA genes identified during the analysis.
• During the analysis, the prevalence of Leigh Syndrome was determined to be 1 in 5,000 children in Japan.
• Based on secondary research classical form of Leigh syndrome accounts for nearly 80% of cases.
• The epidemiology of Leigh syndrome is expected to change during the forecast period (2024-2034).
• The leading Leigh Syndrome Companies such as PTC Therapeutics, Abliva AB, and others.
• Promising Leigh Syndrome Pipeline Therapies such as Vatiquinone, NV354, and others

Stay ahead in the Leigh Syndrome Therapeutics Market with DelveInsight's Strategic Report @ Leigh Syndrome Market Outlook- https://www.delveinsight.com/sample-request/leigh-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Leigh Syndrome Epidemiology Segmentation in the 7MM
• Total Prevalence of Leigh Syndrome
• Prevalent Cases of Leigh Syndrome by severity
• Gender-specific Prevalence of Leigh Syndrome
• Diagnosed Cases of Episodic and Chronic Leigh Syndrome

Download the report to understand which factors are driving Leigh Syndrome Epidemiology Trends @ Leigh Syndrome Prevalence- https://www.delveinsight.com/sample-request/leigh-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Leigh Syndrome Drugs Market
The Leigh syndrome market is expected to experience gradual changes, mainly due to the limited availability of emerging therapies in this area. Key market players, including Abliva AB, and others have demonstrated a keen interest in this condition and are actively pursuing the development of potential treatments.

Emerging Leigh Syndrome Drugs
• NV354: Abliva AB
NV354 is being developed for mitochondrial disease with neurologic complications, in particular at insufficient activity in the mitochondrial protein complex I. The resulting deficiency in energy conversion contributes to clinical signs and symptoms in many types of mitochondrial disease, including neurologic complications seen in Leigh syndrome, MELAS, or LHON.

To learn more about Leigh Syndrome treatment guidelines, visit @ Leigh Syndrome Treatment Market Landscape- https://www.delveinsight.com/sample-request/leigh-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Leigh Syndrome Market Report
• Study Period: 2020-2034
• Coverage: 7MM
• Leigh Syndrome Companies: PTC Therapeutics, Abliva AB, and others
• Leigh Syndrome Therapies: Vatiquinone, NV354, and others
• Leigh Syndrome Therapeutic Assessment: Leigh Syndrome current marketed and Leigh Syndrome emerging therapies
• Leigh Syndrome Market Dynamics: Leigh Syndrome market drivers and Leigh Syndrome market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Leigh Syndrome Unmet Needs, KOL's views, Analyst's views, Leigh Syndrome Market Access and Reimbursement

Learn more about the FDA-approved drugs for Leigh Syndrome @ Drugs for Leigh Syndrome Treatment- https://www.delveinsight.com/sample-request/leigh-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1 Key Insights
2 Leigh Syndrome Report Introduction
3 Leigh Syndrome Market Overview at a Glance
4 Leigh Syndrome Epidemiology and Market Methodology
5 Leigh Syndrome Executive Summary
6 Leigh Syndrome Key Events
7 Disease Background and Overview: Leigh Syndrome
8 Leigh Syndrome Epidemiology and Patient Population
9 Leigh Syndrome Patient Journey
10 Leigh Syndrome: Seven Major Market Analysis
11 Key Opinion Leaders' Views
12 Leigh Syndrome Unmet Needs
13 Leigh Syndrome SWOT Analysis
14 Leigh Syndrome Market Access and Reimbursement
15 Appendix
16 DelveInsight Capabilities
17 Disclaimer
18 About DelveInsight

List of Top Selling Market Research Reports in 2025

Biopsy devices market- https://www.delveinsight.com/report-store/biopsy-devices-market
Diabetic wound market - https://www.delveinsight.com/report-store/diabetic-wounds-market
Joint reconstruction devices market- https://www.delveinsight.com/report-store/joint-reconstruction-devices-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
Spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Cystic fibrosis market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Heart failure market- https://www.delveinsight.com/report-store/congestive-heart-failure-market
NK Cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Positive airway pressure device market - https://www.delveinsight.com/report-store/positive-airway-pressure-device-market
Stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
Surgical sealant market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Thyroid cancer market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Urinary catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Intraocular lens market- https://www.delveinsight.com/report-store/intraocular-lens-market
Uterine fibroids market- https://www.delveinsight.com/report-store/uterine-leiomyoma-uterine-fibroids-market
Attention deficit hyperactivity disorder adhd market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Lice infestations market- https://www.delveinsight.com/report-store/lice-infestations-market
Lymphoedema market- https://www.delveinsight.com/report-store/lymphoedema-market
Dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Leigh Syndrome Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight | PTC Therapeutics, Abliva AB here

News-ID: 3932399 • Views: …

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…

All 5 Releases


More Releases for Leigh

Leigh Syndrome Pipeline | Clinical Trials, Key Companies- PTC Therapeutics
DelveInsight's, "Leigh Disease - Pipeline Insight, 2023," report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in the Leigh Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Download Sample Report to know more @ https://www.delveinsight.com/sample-request/kaposis-sarcoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr Leigh Syndrome…
Current Market Scenario of Global Leigh Syndrome Treatment Market
This report also researches and evaluates the impact of Covid-19 outbreak on the Leigh Syndrome Treatment industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Leigh Syndrome Treatment and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.). Global Leigh Syndrome Treatment Market Overview: The latest report on the global Leigh Syndrome Treatment market suggests a positive growth rate in the coming years.…
Global Seafood Market Research Report 2017: Leigh Fisheries
In this report, the global Seafood market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Seafood in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Fill…
Dr. Leigh-Davis Has "This Is It" Bikini Shoot
Like Elle MacPherson, Dr. Leigh-Davis is saying goodbye to bikini shoots, while the younger Heidi Klum keeps going strong. Dr. Leigh-Davis, founder of the United Kingdom (UK) website "Fabulous Over 40," still feels fabulous but will no longer be posing in bikinis. In her younger days, Dr. Leigh-Davis was a well-known swimsuit model who was even a Ms. Hawaiian Tropic beauty pageant winner. Now, after turning 40 some years ago, Dr.…
Dr. Leigh-Davis is Now a Proponent of Online Education
Having only dabbled in the online education market, law professor Dr. Leigh-Davis was skeptical, but now she is aiding in the development of an online education platform. Having recently returned from a lecture series in London, England, Dr. Leigh-Davis was exploring all types of teaching opportunities. Although regularly giving general lectures, Dr. Leigh-Davis’ forte is as a graduate school professor with her areas of expertise being anthropology and law. Among other…
Dr. Leigh-Davis Talks Brits; Ladies; & Blue-Eyed Soul
Dr. Leigh-Davis can’t wait for the release of her 90 minute Ken Burn’s style documentary on blue-eyed soul. Dr. Leigh-Davis, a former entertainment attorney in the music industry, has been longing to establish herself as a documentary filmmaker, and now has something in development. In conjunction with the production company Creative Endeavors, Dr. Leigh-Davis is slated to produce a documentary on blue-eyed soul. “Music is my passion, and I…